Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC390211929;11930;11931 chr2:178741529;178741528;178741527chr2:179606256;179606255;179606254
N2AB358510978;10979;10980 chr2:178741529;178741528;178741527chr2:179606256;179606255;179606254
N2ANoneNone chr2:Nonechr2:None
N2B353910840;10841;10842 chr2:178741529;178741528;178741527chr2:179606256;179606255;179606254
Novex-1366411215;11216;11217 chr2:178741529;178741528;178741527chr2:179606256;179606255;179606254
Novex-2373111416;11417;11418 chr2:178741529;178741528;178741527chr2:179606256;179606255;179606254
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: I
  • RefSeq wild type transcript codon: ATA
  • RefSeq wild type template codon: TAT
  • Domain: Ig-27
  • Domain position: 83
  • Structural Position: 168
  • Q(SASA): 0.617
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
I/M rs368845723 -0.233 None N 0.205 0.105 None gnomAD-2.1.1 3.18E-05 None None None None I None 0 0 None 0 0 None 0 None 0 6.48E-05 0
I/M rs368845723 -0.233 None N 0.205 0.105 None gnomAD-3.1.2 1.31E-05 None None None None I None 0 0 0 0 0 None 0 0 2.94E-05 0 0
I/M rs368845723 -0.233 None N 0.205 0.105 None gnomAD-4.0.0 4.95726E-06 None None None None I None 4.00299E-05 0 None 0 0 None 0 0 4.23791E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
I/A 0.1666 likely_benign 0.1349 benign -1.257 Destabilizing None N 0.208 neutral None None None None I
I/C 0.5126 ambiguous 0.4699 ambiguous -0.592 Destabilizing 0.132 N 0.453 neutral None None None None I
I/D 0.426 ambiguous 0.3508 ambiguous -0.612 Destabilizing 0.009 N 0.353 neutral None None None None I
I/E 0.3088 likely_benign 0.2593 benign -0.658 Destabilizing 0.002 N 0.363 neutral None None None None I
I/F 0.1258 likely_benign 0.1082 benign -1.0 Destabilizing 0.021 N 0.431 neutral None None None None I
I/G 0.429 ambiguous 0.355 ambiguous -1.518 Destabilizing None N 0.378 neutral None None None None I
I/H 0.314 likely_benign 0.2777 benign -0.716 Destabilizing 0.132 N 0.507 neutral None None None None I
I/K 0.1989 likely_benign 0.1748 benign -0.712 Destabilizing 0.001 N 0.365 neutral N 0.441381949 None None I
I/L 0.1072 likely_benign 0.0955 benign -0.647 Destabilizing None N 0.185 neutral N 0.450821427 None None I
I/M 0.091 likely_benign 0.0815 benign -0.442 Destabilizing None N 0.205 neutral N 0.485866674 None None I
I/N 0.1426 likely_benign 0.1241 benign -0.419 Destabilizing 0.009 N 0.361 neutral None None None None I
I/P 0.688 likely_pathogenic 0.5916 pathogenic -0.818 Destabilizing 0.018 N 0.406 neutral None None None None I
I/Q 0.2595 likely_benign 0.229 benign -0.641 Destabilizing None N 0.418 neutral None None None None I
I/R 0.142 likely_benign 0.1228 benign -0.098 Destabilizing None N 0.415 neutral N 0.383227261 None None I
I/S 0.1362 likely_benign 0.1159 benign -0.965 Destabilizing None N 0.316 neutral None None None None I
I/T 0.0909 likely_benign 0.0773 benign -0.897 Destabilizing None N 0.199 neutral N 0.361178016 None None I
I/V 0.0668 likely_benign 0.0636 benign -0.818 Destabilizing None N 0.103 neutral N 0.444503174 None None I
I/W 0.6463 likely_pathogenic 0.606 pathogenic -1.027 Destabilizing 0.316 N 0.427 neutral None None None None I
I/Y 0.3412 ambiguous 0.3137 benign -0.803 Destabilizing 0.041 N 0.504 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.